IBB vs TLT
iShares Biotechnology ETF vs iShares 20+ Year Treasury Bond ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
TLT—
iShares 20+ Year Treasury Bond ETF
Long-dated US Treasuries (20+ years).
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | TLT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
Holdings data unavailable for IBB.
TLT top holdings
Holdings data unavailable for TLT.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About TLT
TLT (iShares 20+ Year Treasury Bond ETF) is Long-dated US Treasuries (20+ years).